Related references
Note: Only part of the references are listed.Patient Reporting in the EU: Analysis of EudraVigilance Data
Marin Banovac et al.
DRUG SAFETY (2017)
Good Signal Detection Practices: Evidence from IMI PROTECT
Antoni F. Z. Wisniewski et al.
DRUG SAFETY (2016)
ePGA: A Web-Based Information System for Translational Pharmacogenomics
Kleanthi Lakiotaki et al.
PLOS ONE (2016)
Novel oral anticoagulants and the 73rd anniversary of historical warfarin
Abdulla Shehab et al.
JOURNAL OF THE SAUDI HEART ASSOCIATION (2016)
Open Access Pharmacovigilance Databases: Analysis of 11 Databases
Alice Fouretier et al.
PHARMACEUTICAL MEDICINE (2016)
15th ISoP Annual Meeting “Cubism in Pharmacovigilance” Prague, Czech Republic 27-30 October, 2015
DRUG SAFETY (2015)
A Description of Signals During the First 18 Months of the EMA Pharmacovigilance Risk Assessment Committee
Alexandra C. Pacurariu et al.
DRUG SAFETY (2014)
Use of novel oral anticoagulant agents in atrial fibrillation: current evidence and future perspective
Shivanshu Madan et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2014)
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
Rickard E. Malmstrom et al.
FRONTIERS IN PHARMACOLOGY (2013)
Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs
Brian Godman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data A Retrospective Evaluation of the Potential for Earlier Signalling
Yolanda Alvarez et al.
DRUG SAFETY (2010)
ABSTRACTS: 10th ISoP Annual Meeting ‘Pharmacovigilance in the Global Village’ Accra, Ghana 3—6 November 2010
&NA;
DRUG SAFETY (2010)
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
SJW Evans et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
Share Paper
